Previous close | 28.60 |
Open | 28.60 |
Bid | 31.40 x 40000 |
Ask | 33.00 x 43500 |
Day's range | 28.60 - 28.60 |
52-week range | 17.78 - 30.52 |
Volume | |
Avg. volume | 7,566 |
Market cap | 30.604B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.66 |
Earnings date | 28 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 12 May 2022 |
1y target est | N/A |
PetIQ (PETQ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Philips Ingenia Ambition helium-free MR scanner Philips Azurion interventional suite Philips patient monitors October 3, 2024 Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower cost Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced significant greenhouse gas (GHG) emissions reduction results following co
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the new Philips Avent Premium Connected Baby Monitor. With one in two moms finding it challenging to relax when baby is sleeping [2], the Premium Connected Baby Monitor makes the invisible visible, giving parents total reassurance with proprietary SenseIQ sleep and breathing tracking and scientifically-proven Cry Detection and Translation technologies.